The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Open accessAbstract
BACKGROUND: Leukotrienes are inflammatory mediators generated from arachidonic acid (polyunsaturated n-6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis involves arterial inflammation, we hypothesized that a polymorphism in the 5-lipoxygenase gene promoter could relate to atherosclerosis in humans and that this effect could interact with the dietary intake of competing 5-lipoxygenase substrates. METHODS: We determined 5-lipoxygenase genotypes, carotid-artery intima-media thickness, and markers of inflammation in a randomly sampled cohort of 470 healthy, middle-aged women and men from the Los Angeles Atherosclerosis Study. Dietary arachidonic acid and marine n-3 fatty acids (including a competing 5-lipoxygenase substrate that reduces the production of inflammatory leukotrienes) were measured with the use of six 24-hour recalls of food intake. RESULTS: Variant 5-lipoxygenase genotypes (lacking the common allele) were found in 6.0 percent of the cohort. Mean (+/-SE) intima-media thickness adjusted for age, sex, height, and racial or ethnic group was increased by 80+/-19 microm (95 percent confidence interval, 43 to 116; P<0.001) among carriers of two variant alleles, as compared with carriers of the common (wild-type) allele. In multivariate analysis, the increase in intima-media thickness among carriers of two variant alleles (62 microm, P<0.001) was similar in this cohort to that associated with diabetes (64 microm, P=0.01), the strongest common cardiovascular risk factor. Increased dietary arachidonic acid significantly enhanced the apparent atherogenic effect of genotype, whereas increased dietary intake of n-3 fatty acids blunted the effect. Finally, the plasma level of C-reactive protein, a marker of inflammation, was increased by a factor of 2 among carriers of two variant alleles as compared with that among carriers of the common allele. CONCLUSIONS: Variant 5-lipoxygenase genotypes identify a subpopulation with increased atherosclerosis. The observed diet-gene interactions further suggest that dietary n-6 polyunsaturated fatty acids promote, whereas marine n-3 fatty acids inhibit, leukotriene-mediated inflammation that leads to atherosclerosis in this subpopulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Self-citationO'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Drazen, J. M., Yandava, C. N., Dubé, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 560
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422
Self-citationSperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., & Robinson, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116245 · Cited by 349
Dwyer, J. H., Navab, M., Dwyer, K. M., Hassan, K., Sun, P., Shircore, A., Hama-Levy, S., Hough, G., Wang, X., Drake, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.24.2922 · Cited by 337
Self-citationIn, K. H., Asano, K., Beier, D., Grobholz, J., Finn, P. W., Silverman, E. K., Silverman, E. S., Collins, T., Fischer, A. R., Keith, T. P., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119241 · Cited by 334
Computerized collection and analysis of dietary intake information
Feskanich, D., Sielaff, B. H., Chong, K., & Buzzard, I. M. (1989) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(89)90122-3 · Cited by 303
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
Kelley, D. S., Taylor, P. C., Nelson, G. J., Schmidt, P. C., Ferretti, A., Erickson, K. L., Yu, R., Chandra, R. K., & Mackey, B. E. (1999) · Lipids · doi:10.1007/s11745-999-0369-5 · Cited by 252
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247
Serhan, C. N. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00001-4 · Cited by 241
Cayatte, A. J., Du, Y., Oliver-Krasinski, J., Lavielle, G., Verbeuren, T. J., & Cohen, R. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1724 · Cited by 237
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
Shen, J., Herderick, E., Cornhill, J. F., Zsigmond, E., Kim, H. S., Kühn, H., Guevara, N. V., & Chan, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119029 · Cited by 233
Cyrus, T., Praticò, D., Zhao, L., Witztum, J. L., Rader, D. J., Rokach, J., FitzGerald, G. A., & Funk, C. D. (2001) · Circulation · doi:10.1161/01.cir.103.18.2277 · Cited by 232
Zee, R. Y. L., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00703-1 · Cited by 208
Boekholdt, S. M., Bijsterveld, N. R., Moons, A. H. M., Levi, M., Büller, H. R., & Peters, R. J. G. (2001) · Circulation · doi:10.1161/hc5001.100793 · Cited by 202
Altered inflammatory responses in leukotriene-deficient mice.
Goulet, J. L., Snouwaert, J. N., Latour, A. M., Coffman, T. M., & Koller, B. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12852 · Cited by 189
Kelley, D. S., Taylor, P. C., Nelson, G. J., & Mackey, B. E. (1998) · Lipids · doi:10.1007/s11745-998-0187-9 · Cited by 143
Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery
Köller, M., Senkal, M., Kemen, M., König, W., Zumtobel, V., & Muhr, G. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0592 · Cited by 129
Silverman, E. S., Du, J., Sanctis, G. T. D., Rådmark, O., Samuelsson, B. O., Drazen, J. M., & Collins, T. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.2.3154 · Cited by 123
Differential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112
Lötzer, K., Spanbroek, R., Hildner, M., Urbach, A., Heller, R., Bretschneider, E., Galczenski, H., Evans, J. F., & Habenicht, A. J. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082690.23131.cb · Cited by 106
Lee, T. H., Sethi, T., Crea, A., et al. (1988) · Clinical Science · doi:10.1042/cs0740467 · Cited by 94
Li, B., Birdwell, C., & Whelan, J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39782-0 · Cited by 93
The 5-Lipoxygenase Promoter Is Regulated by DNA Methylation
Uhl, J. H., Klan, N., Rose, M., Entian, K., Werz, O., & Steinhilber, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107665200 · Cited by 92
Sjöström, M., Johansson, A., Schröder, O., Qiu, H., Palmblad, J. E. W., & Haeggström, J. Z. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082689.46538.df · Cited by 77
Sol Sherry Lecture in Thrombosis: Molecular Events in Acute Inflammation
Prescott, S. M., McIntyre, T. M., Zimmerman, G. A., & Stafforini, D. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000016153.47693.b2 · Cited by 75
Blood Pressure, LDL Cholesterol, and Intima-Media Thickness
Sun, P., Dwyer, K. M., Merz, C. N. B., Sun, W., Johnson, C. A., Shircore, A. M., & Dwyer, J. H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.2005 · Cited by 69
Self-citationIncreased dietary arachidonic acid enhances the synthesis of vasoactive eicosanoids in humans
Ferretti, A., Nelson, G. J., Schmidt, P. C., Kelley, D. S., Bartolini, G., & Flanagan, V. P. (1997) · Lipids · doi:10.1007/s11745-997-0057-5 · Cited by 67
Serhan, C. N., Takano, T., Chiang, N., Gronert, K., & Clish, C. B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-19 · Cited by 66
Assessment of individual fatty acid intake
Cantwell, M. M. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000203 · Cited by 66
Toll-like receptor 4 polymorphisms and atherogenesis in humans
University Clinic Innsbruck (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)80331-2 · Cited by 66
Automated intima-media thickness: the Los Angeles atherosclerosis study
Dwyer, J. H., Sun, P., Kwong-Fu, H., Dwyer, K. M., & Selzer, R. H. (1998) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(98)00069-6 · Cited by 42
Self-citation5-Lipoxygenase-Derived Leukotrienes: Mediators Also of Atherosclerotic Inflammation
Rådmark, O. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082460.58448.01 · Cited by 42
Serio, K. J., Hodulik, C. R., & Bigby, T. D. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.2.4042 · Cited by 21
Homocysteine and arterial occlusive disease: a concise review.
Andreotti, F., Burzotta, F., Mazza, A., Manzoli, A., Robinson, K., & Maseri, A. (1999) · PubMed · Cited by 14
Cited by
Simopoulos, A. P. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-mr-311 · Cited by 2,915
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Metadata
- Authors
- Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-01
- Volume
- 350
- Issue
- 1
- Pages
- 29-37
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2035093916
- Cited by
- 619
- References
- 49
- FWCI
- 39.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.